During the visit, Anite commended the innovation and resilience of Ugandan entrepreneurs in the health sector.
She stressed that supporting local pharmaceutical manufacturers is critical for boosting the economy and advancing the government’s Buy Uganda, Build Uganda (BUBU) policy.
“NMS needs to start supporting local industries, like these people. Let’s close that gap of importing medicine,” Anite said.
Uganda’s pharmaceutical manufacturing sector is advancing but remains dwarfed by its reliance on imports.
A handful of pioneering companies, including QCIL, are spearheading local production, while policies under the National Medicines Policy and BUBU initiative provide a supportive framework.
However, experts say the real impact depends on addressing systemic challenges: making manufacturing cost-effective, streamlining regulations, scaling production, and ensuring rural access.
Anite highlighted the urgent need for government institutions like NMS to create a stable market for local manufacturers.
She noted that doing so would drive job creation, reduce foreign exchange losses, and strengthen Uganda’s industrial base.
The minister also emphasized the importance of land access, tax incentives, and streamlined regulatory support to accelerate the growth of indigenous pharmaceutical companies.
Her tour forms part of a wider government effort to spotlight homegrown industries capable of replacing imports and fostering sustainable economic growth.
Anite’s message serves as a rallying call for policymakers, procurement agencies, and citizens to prioritize Ugandan-made solutions, starting with healthcare.